Physician profile
Vernon M Smith
NPI 1144294638
$3,477.14
in general payments reported to CMS, 2019-2025
31 companies · $622 in 2025
The $622 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $177 · 2021: $250 · 2022: $371 · 2023: $881 · 2024: $639 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,142.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $671.19 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $521.43 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $329.42 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $305.80 | 2019-2025 | Repatha, Otezla, Evenity |
| Janssen Pharmaceuticals, INC | $231.65 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $214.04 | 2019-2025 | Breztri, Airsupra, Nexium |
| Abbvie INC. | $157.19 | 2021-2023 | Ubrelvy |
| Pfizer INC. | $131.06 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $121.84 | 2023-2025 | Rexulti |
| Astellas Pharma US INC | $100.91 | 2019-2020 | |
| Amarin Pharma, INC. | $92.12 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.93 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $58.98 | 2019-2023 | Seglentis, Livalo |
| Novo Nordisk INC | $54.28 | 2021-2024 | Saxenda, Wegovy |
| Amneal Pharmaceuticals LLC | $43.87 | 2022-2023 | Rytary |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $43.11 | 2022 | |
| Nestle Healthcare Nutrition INC. | $36.92 | 2021-2022 | |
| Sanofi Pasteur INC. | $31.07 | 2019-2022 | |
| Inogen, INC. | $29.00 | 2025 | |
| Axsome Therapeutics, INC. | $22.32 | 2025 | Symbravo |
| Abbott Laboratories | $21.76 | 2024 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $20.99 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $20.80 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $20.49 | 2024 | Eliquis |
| Radius Health, INC. | $20.04 | 2023 | Tymlos |
| Seqirus USA INC | $19.24 | 2025 | Flucelvax, Fluad |
| Lucid Diagnostics INC. | $17.66 | 2022 | |
| Ekos Corporation | $15.36 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.69 | 2023 | |
| Merck Sharp & Dohme LLC | $13.13 | 2019 | |
| Vertical Pharmaceuticals, LLC | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vernon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.